Announced
PharmEasy to acquire a 66.14% stake in Thyrocare for $614m.
Synopsis
PharmEasy, an online medicine delivery startup, agreed to acquire a 66.14% stake in Thyrocare Technologies, a chain of diagnostic and preventive care laboratories, for $614m. The acquisition has triggered an open offer under which PharmEasy will acquire up to 26% shareholding in the company from public shareholders.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.